Search research articles
Contact Us
Filters
Showing results (191-200 of 332) with videos related to
Page
of 34
Sort By:
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
November 4, 2015
miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease
Gohar Mushtaq, Nigel H Greig, Firoz Anwar, et al.
CNS & Neurological Disorders Drug Targets
|
April 10, 2012
A synopsis on the role of tyrosine hydroxylase in Parkinson's disease
Shams Tabrez, Nasimudeen R Jabir, Shazi Shakil, et al.
Current Alzheimer Research
|
December 20, 2014
Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease
Robert J Baranello, Krishna L Bharani, Vasudevaraju Padmaraju, et al.
Current Pharmaceutical Design
|
November 26, 2015
Neuroprotective Mechanisms Mediated by CDK5 Inhibition
Gohar Mushtaq, Nigel H Greig, Firoz Anwar, et al.
Trends in Neurosciences
|
February 14, 2017
Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms
Jesse S Kerr, Bryan A Adriaanse, Nigel H Greig, et al.
Oncotarget
|
April 28, 2016
In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems
Shaunna L Beedie, Holly M Rore, Shelby Barnett, et al.
Journal of Medicinal Chemistry
|
November 14, 2003
Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity
Xiaoxiang Zhu, Tony Giordano, Qian-Sheng Yu, et al.
European Journal of Pharmacology
|
June 22, 2005
Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats
Gilberto N Carmona, Charles W Schindler, Nigel H Greig, et al.
CNS & Neurological Disorders Drug Targets
|
September 18, 2014
Quinoline derivatives: candidate drugs for a class B G-protein coupled receptor, the calcitonin gene-related peptide receptor, a cause of migraines
Hira Iftikhar, Iqra Ahmad, Siew H Gan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 28, 2006
The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice
Debomoy K Lahiri, DeMao Chen, Bryan Maloney, et al.
Page
of 34
Search research articles
Search
Showing results (191-200 of 332) with videos related to
Sort By:
Page
of 34
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
November 4, 2015
miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease
Gohar Mushtaq, Nigel H Greig, Firoz Anwar, et al.
CNS & Neurological Disorders Drug Targets
|
April 10, 2012
A synopsis on the role of tyrosine hydroxylase in Parkinson's disease
Shams Tabrez, Nasimudeen R Jabir, Shazi Shakil, et al.
Current Alzheimer Research
|
December 20, 2014
Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease
Robert J Baranello, Krishna L Bharani, Vasudevaraju Padmaraju, et al.
Current Pharmaceutical Design
|
November 26, 2015
Neuroprotective Mechanisms Mediated by CDK5 Inhibition
Gohar Mushtaq, Nigel H Greig, Firoz Anwar, et al.
Trends in Neurosciences
|
February 14, 2017
Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms
Jesse S Kerr, Bryan A Adriaanse, Nigel H Greig, et al.
Oncotarget
|
April 28, 2016
In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems
Shaunna L Beedie, Holly M Rore, Shelby Barnett, et al.
Journal of Medicinal Chemistry
|
November 14, 2003
Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity
Xiaoxiang Zhu, Tony Giordano, Qian-Sheng Yu, et al.
European Journal of Pharmacology
|
June 22, 2005
Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats
Gilberto N Carmona, Charles W Schindler, Nigel H Greig, et al.
CNS & Neurological Disorders Drug Targets
|
September 18, 2014
Quinoline derivatives: candidate drugs for a class B G-protein coupled receptor, the calcitonin gene-related peptide receptor, a cause of migraines
Hira Iftikhar, Iqra Ahmad, Siew H Gan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 28, 2006
The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice
Debomoy K Lahiri, DeMao Chen, Bryan Maloney, et al.
Page
of 34